Showing posts with label oxitec. Show all posts
Showing posts with label oxitec. Show all posts

Wednesday, June 11, 2014

The New X-men Generation: how mutant mosquitoes will save the world


For my first blog post, I thought I'd bring back one of my favorite topics that I first read about last year. I heard about genetically modified mosquitoes on the news again recently, so I decided to expand and write a lengthy (blog post) but a short essay on this new technology. Enjoy! 


Brief points:
  • There are several advantages of GMMs over traditional interventions of insecticides, bed nets and SIT.
  • Among the various GMM methods, RIDL currently holds the most evidence of effectiveness so far. While RNAi and Wombachia are promising ideas, more studies in the laboratory and field are needed to evaluate its effects to different strains of dengue and possible resistance.
  • In addition to considering biological factors, there are also social and economic aspects including cost-effectiveness, community acceptance, and long-term sustainability with capacity building to consider.
  • For greater uptake within communities, more accurate information of its advantages and misconceptions should be addressed.


Background

According to WHO, around 50-100 million people are affected each year from dengue fever, one of the deadliest mosquito-borne diseases, primarily in tropical and sub-tropical regions1. While many interventions have been carried out to fight against vector-borne diseases, they have been ineffective to completely eradicate it. However, today’s technological advancements have allowed the development of promising innovative methods, including one that targets the mosquito population with genetic modifying mechanisms. Scientists have described this new approach as a “quantum leap” which has the potential to revolutionize, and possibly eradicate, malaria transmission. The idea of this “mutant mosquito” gained widespread attention and popularity through a TED talk from Oxitec. Since then, many institutions particularly in the UK have developed on this idea creating waves in the scientific community.  

Genetic modification (GM) serves as an incredibly useful tool that has been the subject of unfair and biased criticism2. Genetically modified mosquitoes (GMM) have several advantages to other techniques such as SIT (Sterile Insect Technique) and traditional methods of insecticides and bed nets. And while there are several ways in which to genetically modify a mosquito, such as the use of RNAi and Wolbachia, the RIDL (release of insects carrying a dominant lethal gene) technique seems to be the most effective and sustainable GM technique for the eradication of vector-borne disease. Oxitec, a biotechnology company, has used the RIDL technique to demonstrate short-term success in the Cayman Islands, Malaysia, and Brazil2.


The traditional methods

Traditional methods of pesticides and larvicides have not been fully effective at reducing disease transmission and face many challenges due to resistance and unsustainable high costs3. The challenge is that mosquitoes have many breeding site options within a community, and targeting every source of water with chemicals is impractical and restricted due to potential human toxicity3. Furthermore, the Ae. Aegypti species, which primarily transmits dengue, is a day-biter making the use of bed nets generally ineffective4. In response to these challenges, scientists in the past have used a technique known as SIT. The SIT technique is an insect population control method where mosquitoes are sterilized by irradiation then released to mate with wild mosquitoes, which would hopefully produce fewer progeny5. One of the largest issues with SIT is the emergence of behavioural resistance due to decreased fitness of the irradiated males5. In some cases, females are able to identify the sterile males and avoid mating with them. So far, there have been no signs of resistance to the RIDL modified mosquitoes5. Because of this adaptation of the resistance among female mosquitoes, SIT is an unsustainable method.


The new approach

To improve upon these challenges, scientists at Oxitec are utilizing GMM strategies, which may be safer and more effective than SIT4. One of the most effective GMM techniques is known as RIDL. RIDL, also known as conditional lethality, modifies male mosquitoes not by irradiation, but by genetically modifying a mosquito to carry a dominant lethal6. When this transgene is activated – there are several activation methods - it can cause lethality in progeny. The most important advantage of RIDL over SIT is the ability to control the activation of the lethal gene allowing it to be sex-specific and to time lethality6.

Oxitec has developed two main activation methods:  

(1) The first approach is sex-specific which aims to create flightless female. A construct is developed to reduce the expression of a female-specific gene that is critical for flight in pupae. This construct is inserted into the strain of male mosquitoes7. Once these modified males are released and mate with wild females, the immediate progeny inherits this dominant female-specific lethal gene, and the mutation is expressed in a female mosquito progeny7. This results in F1 females unable to fly to find mates or bite human hosts7. The F1 males, however, remain viable and fertile4. This will decrease the overall reproductive potential of the wild population5. Instead of random mutations caused by SIT, males can carry and deliver female-acting transgenes into the population4.

(2) A second approach of RIDL focuses on stage-specific killing. This allows scientists to control age of mortality, either in pupae, or in adults, and targets both males and females4. One way this is achieved is by inserting mutations so that lethal genes are only expressed in the absence of tetracycline8. A RIDL transgene is created, which carries the instructions for the production of a protein called tetracycline transactivator (tTA), and is inserted into the a strain in Ae. Aegypti mosquitoes9. This transgene is composed of two proteins, which allow it to continuously produce even more tTA protein resulting in a positive feedback loop9. tTA will interefere with the cellular process causing mosquito larvae to die. However in the presence of tetracycline, tTA expression can be turned off by binding to tetracycline9. In other words, scientists can control whether survival of larvae by increasing or removing tetracycline from the environment. Because these constructs use either female or stage-specific promoters, they do not affect male fitness or interfere with other stages of a mosquito’s life4. This helps ensure stability of the mosquito’s competitiveness in the wild and reduces the possibility of resistance, which has been a challenge for the SIT method.

Figure 1. Because I always love drawn out explanations, I outlined the stage-specific killing method (conditional lethality)d below in a detailed and graphic visualization:


Some other new GM methods gaining traction

RNAi: Using RNAi, scientists hope to improve the mosquito’s own natural immune defense system. This method calls for a genetic construct to be developed that expresses copies of an inverted repeat from a dengue virus 2 (DENV-2) genomic RNA4. Once the virus invades the mosquito, the resulting double stranded RNA forms and triggers an RNAi response degrading the virus and protecting the mosquito4. However, this method was only found effective in laboratory so far.

Wolbachia: The other GM technology utilizes the natural symbiotic bacteria Wolbachia, which naturally infects other insects such as Drosophila and protects them against infection by certain RNA viruses10. The idea aims to boost a mosquito’s defense system by infecting A.aegypti mosquitos with Wolbachia to prevent dengue infection10. While this is a promising idea and has been successful in small laboratory studies, it has several limitations. Research has only tested infection to protect against DENV-2; its effectiveness against the three other dengue serotypes has yet to investigated4. On the other hand, the RIDL method that Oxitec has employed eradicates the entire mosquito species with no challenges of targeting virus serotypes. Most importantly, the mechanism of how Wolbachia blocks pathogens is still unknown4. Without knowing this mechanism, it is difficult to foresee long-term effects of implementing Wolbachia in specific mosquito populations and predicting whether they may have adverse effects, such as if resistance will arise and how we may prevent it.

 

Challenges ahead for GM technology

The main challenge for any mosquito suppression technique is sustainability - maintaining stability of the competitiveness of the mosquito and preventing possible resistance4. All of the GM techniques including RIDL, have not been tested long enough yet to ascertain long-term effects. However, RIDL has shown successful short-term effects thus far. In 2010, male mosquitoes with modified strains were released in field tests in the Cayman Islands; the results showed a reduction in A.aegypti population by 80%2. Currently, RIDL technologies have only used single gene insertions. To avoid the possibility of resistance, future studies can introduce several conditional lethal systems in a genome8. RIDL future intervention programs will most likely be used in combination with other traditional or GM methods to boost effectiveness3.


Misconceptions and advantage

  • The most common belief is that scientists are aiming to eradicate all mosquitoes, which would possibly disrupt ecological systems. However, the focus of GMM research is on specific species that transmit disease-causing pathogens to humans, most of which are invasive species in an area in the first place3.
  • RIDL has several advantages in safety and in acceptance within a community. If RIDL is successful, the population can anticipate a short-lived presence of the GMM in their community once the mosquito species has been eradicated11. Since only males are released, it may also reduce nuisance biting and the risk of crop damage from egg-laying females11. These mosquitoes can also be manufactured and released locally after training communities allowing for capacity building and empowerment through employment11.
  • The RIDL technique allows scientists to control lethality timing by controlling tetracycline release to a mosquito’s diet. This tetracycline requirement produces the conditional lethality aspect of RIDL, which also ensures protection against the accidental release of mosquitoes11


References 1. Sifferlin, A. How Mutant Mosquitoes are Fighting Dengue Fever. Time, 9 November 2012. < http://healthland.time.com/2012/11/09/how-mutant-mosquitoes-are-fighting-dengue-fever> 2. Parry, Hadyn. “Re-engineering mosquitos to fight disease.” TedSalon London Fall 2012. November 2012. <http://www.ted.com/talks/hadyn_parry_re_engineering_mosquitos_to_fight_disease.html? 3. Benedict, M.Q., James, A.A., and Collins, F.H. (2011) Safety of Genetically Modified Mosquitoes. JAMA, 305 (20). 4. McGraw, E.A. and O’Neill, S.L. (2013). Beyond insecticides: new thinking on an ancient problem. Nature Reviews Microbiology, 11. 5. Alphey, N., Bonsall, M.B. and Alphey L. (2011) Modeling resistance to genetic control of insects. Journal of Theoretical Biology, 270: 42-55. 6. Fu, et al. (2010) Female-specific flightless phenotype for mosquito control. PNAS, 107 (10). 7. Wise de Valdez, M.R. et al. (2011) Genetic elimination of dengue vector mosquitoes. PNAS, 108 (12). 8. Black, W.C. Alphey, L., and James A.A. (2011) Why RIDL is not SIT. Trends in Parasitology, 27 (8). 9. AmsianV. Dengue Fever, GMOsquitoes, and a “Wolbachian” Invasion. Amasian Science. 3 January 2013. Web. 25 March 2013. < http://amasianv.wordpress.com/2013/01/03/dengue-fever-gmosquitos-and-a-wolbacchian-invasion/> 10. Le, Viet.  Could Wolbachia be an alternative to dengue-fighting GMOsquitos? Plos Blogs. 3 January 2013. Web. 25 March 2013 < http://blogs.plos.org/publichealth/2013/01/03/could-wolbachia-be-an-alternative-to-dengue-fighting-gmosquitos/> 11. “Oxitec: Benefits of RIDL Science,” Oxitec.com. n.d. Web. 25 March 2013. <http://www.oxitec.com/ridl-science/benefits-of-ridl/>